These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31538891)

  • 1. Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases.
    Dinesh DC; Tamilarasan S; Rajaram K; Bouřa E
    Curr Drug Targets; 2020; 21(2):105-124. PubMed ID: 31538891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections.
    Huchting J
    Antivir Chem Chemother; 2020; 28():2040206620976786. PubMed ID: 33297724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of antivirals: broad-spectrum inhibitors.
    Debing Y; Neyts J; Delang L
    Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular strategies to inhibit the replication of RNA viruses.
    Leyssen P; De Clercq E; Neyts J
    Antiviral Res; 2008 Apr; 78(1):9-25. PubMed ID: 18313769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear trafficking of proteins from RNA viruses: potential target for antivirals?
    Caly L; Wagstaff KM; Jans DA
    Antiviral Res; 2012 Sep; 95(3):202-6. PubMed ID: 22750233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleosides for the treatment of respiratory RNA virus infections.
    Jordan PC; Stevens SK; Deval J
    Antivir Chem Chemother; 2018; 26():2040206618764483. PubMed ID: 29562753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2008 (2nd edition): RNA viruses.
    De Clercq E; Field HJ
    Antivir Chem Chemother; 2008; 19(2):63-74. PubMed ID: 18727441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Virus Capsid as a Tool to Fight RNA Viruses.
    Hozáková L; Vokatá B; Ruml T; Ulbrich P
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based antivirals for emerging and neglected RNA viruses: an emerging field for medicinal chemistry in academia.
    Hilgenfeld R
    Future Med Chem; 2010 Jul; 2(7):1061-7. PubMed ID: 21426155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.
    Furuta Y; Takahashi K; Shiraki K; Sakamoto K; Smee DF; Barnard DL; Gowen BB; Julander JG; Morrey JD
    Antiviral Res; 2009 Jun; 82(3):95-102. PubMed ID: 19428599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acridones as antiviral agents: synthesis, chemical and biological properties.
    Sepúlveda CS; Fascio ML; García CC; D'Accorso NB; Damonte EB
    Curr Med Chem; 2013; 20(19):2402-14. PubMed ID: 23521684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
    Witvrouw M; De Clercq E
    Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein.
    Zhao Y; Cao X; Guo M; Wang X; Yu T; Ye L; Han L; Hei L; Tao W; Tong Y; Xu Y; Zhong J
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stealth nucleosides: mode of action and potential use in the treatment of viral diseases.
    Daifuku R
    BioDrugs; 2003; 17(3):169-77. PubMed ID: 12749753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly pathogenic RNA viral infections: challenges for antiviral research.
    Bray M
    Antiviral Res; 2008 Apr; 78(1):1-8. PubMed ID: 18243346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses.
    Delang L; Abdelnabi R; Neyts J
    Antiviral Res; 2018 May; 153():85-94. PubMed ID: 29524445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B Gene Therapy Coming to Age.
    Soriano V
    AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease.
    Taylor R; Kotian P; Warren T; Panchal R; Bavari S; Julander J; Dobo S; Rose A; El-Kattan Y; Taubenheim B; Babu Y; Sheridan WP
    J Infect Public Health; 2016; 9(3):220-6. PubMed ID: 27095300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel mode of action of ribavirin (Rebetol), a drug for the treatment of chronic hepatitis C: inducting the mutation of RNA viruses].
    Ogawa M; Morisada A
    Nihon Yakurigaku Zasshi; 2002 Dec; 120(6):398-408. PubMed ID: 12528471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection.
    Chen SH; Tan SL
    Curr Med Chem; 2005; 12(20):2317-42. PubMed ID: 16181135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.